How do we manage thrombogenicity and thrombosis in the Fontan? New Horizons...

Space: StayCurrentMD Published:
How do we manage thrombogenicity and thrombosis in the Fontan? New Horizons... podcast cover art

Topic overview

Physicians from theCincinnati Children’s Heart Institutediscuss the long-term care of single ventricle patients from infancy to adulthood, including new insights on Fontan management and quality of life.During this session, Dr. Joseph Palumbo discusses how to manage thrombogenicity and thrombosis in the patient with Fontan. Topics discussed include increasing prothrombotic state secondary to endothelial activation, inflammatory system activation, and hemostatic system activation, as well ascomparison to other thrombophilias, how to decide which patients should have therapeutic anticoagulation.

Keywords

thrombogenicitythrombosisFontan circulationcoagulation cascadethrombotic eventspulmonary embolismthrombophiliaD-dimerfactor 8anticoagulationwarfarinaspirinthromboprophylaxisliver dysfunctionendothelial activationbiomarkersvenous thromboembolismprothrombinhemostatic balancepediatric hematology

Hashtags

#Thrombosis#FontanCirculation#PediatricHematology#Anticoagulation#Thrombogenicity#Coagulation#Thrombophilia#PulmonaryEmbolism#DimerTesting#Factor8#Warfarin#Aspirin#Thromboprophylaxis#LiverDysfunction#EndothelialActivation#Biomarkers#VenousThromboembolism#Prothrombin#Hemostasis#ClinicalResearch
1 Views
0 Comments

Comments

Loading comments...